Boulding Mark Elliott, EVC, reported an open-market or private sale at PTC THERAPEUTICS, INC. involving 1286.000000 shares for an estimated $98314.70. Reported holdings after the transaction were 113626.000000 shares. The stored filing text includes a detected 10b5-1 reference.
Stored Form 4 columns with their raw values
Badges describe filing facts only — not predictions.
Compact filing score computed from stored Form 4 facts. Version v1.
This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.
Form 4 relationship flags and nearby filing context
EXEC. VP AND CLO
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 4, 2024.
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $75.95 to $76.92 per share. The Reporting Person hereby undertakes, u…
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $76.99 to $77.23 per share. The Reporting Person hereby undertakes, u…
Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 3,600 RSUs from a January 7, 2022 grant…
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $77.12 to $78.08 per share. The Reporting Person hereby undertakes, u…
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $78.23 to $79.21 per share. The Reporting Person hereby undertakes, u…
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $79.35 to $79.60 per share. The Reporting Person hereby undertakes, u…
0 other filings
0 recent txs